Olympia Pharmaceuticals Expands into Alabama with New Licensing, Bringing GLP-1s and More to Healthcare Providers
Nation’s leading compound pharmacy is now available in 48 statesORLANDO, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Olympia ...
WuXi moves ahead with new $510M campus in Delaware despite sale of Navy Yard operations
A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...
Medscape6d
Assisted Reproductive Technology Linked to Greater Teratogenic Medicine Use Throughout Pregnancy
Pregnancies achieved through assisted reproductive technology show higher exposure to potentially harmful category D ...
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, ...
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE® Rights ex-US Sale of GOLIKE® Rights Outside the U.S. to Nutrisens Relief to Focus on R&D of Pipeline Assets and Licensing for ...
Skin Is In, Grab the Manscaped Dome Shaver Pro at a Steal and Grab Life By the Bald
The Dome Shaver Pro has a blade pad containing 5 Triple-Track Blade Heads in a curved configuration, meant to hug the natural ...
Stargate: OpenAI's Hard Takeoff And Its Implications On Microsoft
Microsoft is poised for growth with OpenAI and Project Stargate. Find out why MSFT stock is a strong pick while rivals like ...
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Scorpius Holdings, Inc (NYSE American:SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced its collaboration with KaloCyte, ...
Joplin Globe3h
Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development
VANCOUVER, BC / ACCESS Newswire / / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of intent ...